Heparanase is an endo‐acting β‐glucuronidase and the only known enzyme responsible for the regulation of heparan sulfate structures in the extracellular matrix. The enzyme is found to be significantly upregulated in aggressive cancer types, aiding cell proliferation by liberation of growth factors, increasing angiogenesis and metastasis. Despite much interest in the development of inhibitors to control this activity, no compound targeting heparanase has yet reached the clinic. While mechanism‐based inhibitors derived from the epoxide carbocycle cyclophellitol are very potent enzyme inactivators, one challenge in their development is in achieving selectivity for heparanase over related glycosidases. We here present the synthesis of three cyclophellitol scaffolds presenting azide and alkyne handles at key positions, which are amenable to facile elaboration via copper‐catalysed azide‐alkyne cycloadditions to aid in exploring the structure‐activity relationship for selective inhibitors of heparanase.
Read full abstract